Company
Board Member
2024-12-05–present
Grant Bogle
Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Grant Bogle
The company reported in an 8-K filed July 15, 2026 that Grant Bogle resigned as director, effective July 15, 2026. The company reported in an 8-K filed December 9, 2024 that Grant Bogle was appointed member of the Board, effective December 5, 2024.
“In accordance with the Merger Agreement, at the Effective Time, each of the directors of the Company (James R. Porter, Ph.D.; Grant C. Bogle; Michael L. Meyers, M.D., Ph.D.; Christy Oliger; Anna Protopapas; Ron Squarer; Sapna Srivastava, Ph.D.; and Cameron A. Wheeler, Ph.D.) resigned from his or her respective position as a member of the Company's board of directors, and any committee thereof.”
“On December 5, 2024, in accordance with the recommendation of the Nominating and Corporate Governance Committee ("NCG Committee") of the Board of Directors (the "Board") of Nuvalent, Inc. (the "Company"), the Board elected Grant Bogle as a member of the Board, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organization not stated
Board Member
SEC 8-K
Current2024-12-05–present
-
Organization not stated
Board Member
SEC 8-K
2025-06-18–2026-07-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Executive change Resigned: director
-
Executive change Appointed: member of the Board